Gut microbiome of a porcine model of metabolic syndrome and HF-pEF

Authors:

Abstract
Metabolic syndrome (MetS) is a combination of cardiovascular risk factors including obesity, hyperlipidemia, hypertension, insulin resistance, non-alcoholic fatty liver disease and diastolic heart failure. This syndrome has been identified as one of the greatest global health challenges of the 21st century. Herein, we examine in a porcine model of diet-induced MetS whether cardiovascular, metabolic, gut microbiota and functional metataxonomic changes mimic those observed in human studies. Landrace pigs with mineralocorticoid-induced hypertension fed a high-fat, salt and sugar diet (HFD) over 12 weeks were assessed for hyperlipidemia, hyperinsulinemia, immunohistologic, echocardiographic and hemodynamic parameters, as well as assessment of microbiome phenotype and functionality through 16S rRNA gene sequencing, phylogenetic and meta-taxonomic analysis. All MetS animals when compared to controls developed obesity, hyperlipidemia, insulin resistance, hypertension, fatty liver, structural cardiovascular changes including left ventricular hypertrophy and left atrial enlargement, and increased circulating saturated fatty acid levels, in keeping with the human phenotype. A reduction in alpha diversity and specific microbiota changes at phylum, family and genus levels also occurred in this model. Moreover, increases in pro-inflammatory bacteria and secondary bile acid producing bacteria were identified, combined with a decrease in enteroprotective bacteria and a reduction of short chain fatty acid (SCFA)-producing bacteria.Together these data suggest that diet and mineralocorticoid-mediated development of biochemical and cardiovascular stigmata of metabolic syndrome in pigs leads to temporal gut microbiome changes that mimic key gut microbial population signatures in human cardiometabolic disease.
Funding Information
  • Science Foundation Ireland (SFI/12/RC/2273)

This publication has 96 references indexed in Scilit: